Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Diamyd Medical AB

DMYD B.ST ✗ NOT COMPLIANT ☆ Track — members

Nasdaq Stockholm · Healthcare · Biotechnology & Medical Research ·

Sweden Micro Cap Analyst: N/A

Last Close

$0.11

▼ -6.04%

Market Cap $16.75M · Vol 336.72K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$16.75M

Micro Cap

Div Yield

0.00%

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

46.67

Momentum

Beta

1.64

vs Market

52W High

$1.89

94.60% below

52W Low

$0.09

11.69% above

Volume

336.72K

Avg 415.48K

P/B

5.55

Price-to-book

ROE

N/A

Return on equity

Free Float

85.75%

Public shares

Shariah Compliance8 STANDARDS

✗ Diamyd Medical AB (DMYD B.ST) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does DMYD B.ST pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.39%

-0.58%

-9.84%

-93.44%

YTD

-90.89%

-91.06%

-87.50%

-96.51%

Financials & Valuation

TTM · Annual

Total Revenue	$13.77K
Net Income	$-17,985,804.00
Revenue Growth (YoY)	N/A
Gross Margin	100.00%
Operating Margin	-140,950.77%
Net Profit Margin	-130,597.69%
ROE	N/A
ROA · ROIC	-59.60% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	9,781.01
P/B	5.55
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	151.48M

Technical Indicators

50-Day SMA	$0.11
200-Day SMA	$0.73
RSI (14)	46.67
Beta	1.64
52-Week High	$1.89
52-Week Low	$0.09

Volume Today	336.72K
Avg Daily Volume (30D)	415.48K
Relative Volume	0.81x
Volatility (10D)	55.92
Volatility (30D)	38.25
Free Float	85.75%

Analyst Consensus

N/A

Current Price $0.11

Mean Target N/A

52W Low$0.09 52W High$1.89

Current

Target

$0.09 $1.89

Current Analyst target

· 0 analysts

Identifiers

ExchangeNasdaq Stockholm

FIGIBBG004DD90Z0

ISINSE0005162880

CountrySweden

Sub-IndustryBio Therapeutic Drugs

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

2359.HK WuXi AppTec Co Ltd +3.29% ARGX.BR argenx SE +1.74% ARGX argenx SE +0.83% 2269.HK WuXi Biologics (Cayman) Inc +7.41% INSM Insmed Inc -0.07%

Company Profile

Diamyd Medical AB is a Sweden-based diabetes company. It is active in the field of pharmaceutical development and investments in stem cell and medical technology. The Company develops the diabetes vaccine, Diamyd, with the active glutamic acid decarboxylase (GAD) ingredient for the treatment and prevention of autoimmune diabetes. The vaccine is intended for the treatment of children and adolescents with recent-onset type one diabetes, as well as those at high risk of developing the disease.